Twitter Facebook LinkedIn YouTube

Laguna Blends (CSE: LAG) signed Exclusive Canadian Distribution Agreement

Video Platform Video Management Video Solutions Video Player

Laguna Blends Inc., a market leader in the distribution of hemp and cannabidiol products, has signed an exclusive Canadian distribution agreement for its entire product list with a Canadian based distributor of cannabidiol products.

Additional Information:

Company: Isodiol International
Website: http://lagunablends.com
Stock Symbol: CSE:isol
Date Published: Mar 1, 2017
Transcript: Available

Video Transcript:

I’m Samantha Deutscher for Investmentpitch Media

Laguna Blends Inc., a market leader in the distribution of hemp and cannabidiol products, has signed an exclusive Canadian distribution agreement for its entire product list with a Canadian based distributor of cannabidiol products.

As a part of this agreement, Vancouver-based Medigreen will place an initial minimum order of US$250,000, followed by additional monthly orders.

In the last three months, Medigreen generated US$300,000 through their Canada-wide network of dispensaries, manufacturers and product formulators.

Medigreen will have full control of the company’s portfolio, including the recently licensed Isodiol (www.isodiol.com) portfolio of oil, sprays, creams, edibles, and crystalline categories.

This product line also includes hemp and CBD beverages, and the new nano CBD Shots, NanoZzz for sleep, and Amp’d Up for energy.

Ray Grimm Jr., President & CEO of Laguna Blends, stated: “By securing this distribution channel, it allows us to really develop a strong footprint into the Canadian Market. By leveraging our partner's warehousing, logistics and fulfillment capabilities, we are set to address fast growing sales on a national scale. The Canadian market has a rapidly increasing demand for such hemp based CBD products and our high quality portfolio is quickly establishing itself as a market leading solution.”

Laguna will continue to source additional distribution channels for its cannaceutical, Pro369 and other product lines and seek joint ventures and acquisitions in order to expand its portfolio, with plans to aggressively begin international expansion into Asia and Europe in 2017.

Laguna’s growth strategy includes acquiring and incubating companies that formulate and/or manufacture hemp products, which it can market utilizing its B to B network and online marketplace.

The company provides the highest quality hemp product experience to the end user, utilizing a proprietary nanotechnology in many of its consumable and topical skin care products.

The shares are trading at $0.20, well below the $0.80 target price given by Vancouver-based Fundamental Research.

For more information, please visit the company’s websites www.lagunablends.com and https//cbdskincream.com or email ir@lagunablends.com.

Investor relations is handled by Howe and Bay Financial, which can be reached at 604-449-5302 or email info@HoweandBayFinancial.com.

I’m Samantha Deutscher for Investmentpitch Media